Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma

OBJECTIVE: No standard chemotherapy is available for patients with advanced esophageal squamous cell carcinoma (ESCC) who have failed prior first-line chemotherapy. The aim of this study was to evaluate the efficacy and safety of apatinib, an oral VEGFR-2 inhibitor, as salvage treatment for advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianqiang, Wang, Lifen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558584/
https://www.ncbi.nlm.nih.gov/pubmed/28860804
http://dx.doi.org/10.2147/OTT.S132756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558584/
https://www.ncbi.nlm.nih.gov/pubmed/28860804
http://dx.doi.org/10.2147/OTT.S132756

Ejemplares similares